1)American Academy of Ophthalmology. Basic and Clinical Science Course Section 10:Glaucoma. Singapore:American Academy of Ophthalmology. 2008.
2)Renard E, Palombi K, Gronfier C et al:Twenty-four hour(nyctohemeral)rhythm of intraocular pressure and ocular perfusion pressure in normal-tension glaucoma. Invest Ophthalmol Vis Sci 51:882-889, 2010
3)Liu JH, Zhang X, Kripke DF et al:Twenty-four-hour intraocular pressure pattern associated with early glaucomatous changes. Invest Ophthalmol Vis Sci 44:1586-1590, 2003
4)Cheng J, Xiao M, Xu H et al:Seasonal changes of 24-hour intraocular pressure rhythm in healthy shanghai population. Medicine(Baltimore) 95:e4453, 2016
5)http://bjo.bmj.com/content/bjophthalmol/101/4/1.full.pdf.
6)Inoue T, Tanihara H:Ripasudil hydrochloride hydrate:targeting Rho kinase in the treatment of glaucoma. Expert Opin Pharmacother 18:1669-1673, 2017
7)Kaneko Y, Ohta M, Inoue T et al:Effects of K-115(Ripasudil), a novel ROCK inhibitor, on trabecular meshwork and Schlemm's canal endothelial cells. Sci Rep 6:19640, 2016
8)Lavia C, Dallorto L, Maule M et al:Minimally-invasive glaucoma surgeries(MIGS)for open angle glaucoma:A systematic review and meta-analysis. PLoS One 12:e0183142, 2017
9)Amoozgar B, Phan EN, Lin SC et al:Update on ciliary body laser procedures. Curr Opin Ophthalmol 28:181-186, 2017
10)https://www.aao.org/headline/continuous-iop-monitoring-implant-approved-in-euro.
11)Ittoop SM, SooHoo JR, Seibold LK et al:Systematic review of current devices for 24-h intraocular pressure monitoring. Adv Ther 33:1679-1690, 2016